Altered expression of β-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis

Carcinogenesis

Volumn 21, Issue 7, 2000, Pages 1319-1327

  Takahashi, Mami ^a   Mutoh, Michihiro ^a   Kawamori, Toshihiko ^a   Sugimura, Takashi ^a   Wakabayashi, Keiji ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; BETA CATENIN; CYCLOOXYGENASE 2; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL CARCINOGENESIS; COLON ADENOCARCINOMA; COLON ADENOMA; COLON CARCINOGENESIS; CONTROLLED STUDY; CRYPT CELL; GENE MUTATION; HYPERPLASIA; MALE; NONHUMAN; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0033924401     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.5.319     Document Type: Article

References (56)

1. Miller, J.R. and Moon, R.T. (1996) Signal transduction through β-catenin and specification of cell fate during embryogenesis. Genes Dev., 10, 2527-2539.
2. Rubinfeld, B., Souza, B., Albert, I., Müller, O., Chamberlain, S.H., Masiarz, F.R., Munemitsu, S. and Polakis, P. (1993) Association of the APC gene product with β-catenin. Science, 262, 1731-1734.
3. Munemitsu, S., Albert, I., Souza, B., Rubinfeld, B. and Polakis, P. (1995) Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl Acad. Sci. USA, 92, 3046-3050.
4. Yost, C., Torres, M., Miller, J.R., Huang, E., Kimelman, D. and Moon, R.T. (1996) The axis-inducing activity, stability, and subcellular distribution of β-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev., 10, 1443-1454.
5. Morin, P.J., Sparks, A.B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B. and Kinzler, K.W. (1997) Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science, 275, 1787-1790.
6. Sparks, A.B., Morin, P.J., Vogelstein, B. and Kinzler, K.W. (1998) Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res., 58, 1130-1134.
7. Ambs, S., Merriam, W.G., Bennett, W.P., Felley-Bosco, E., Ogunfusika, M.O., Oser, S.M., Klein, S., Shields, P.G., Billiar, T.R. and Harris, C.C. (1998) Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res., 58, 334-341.
8. Eberhart, C.E., Coffey, R.J., Radhika, A., Giardiello, F.M., Ferrenbach, S. and DuBois, R.N. (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188.
9. Erdman, S.H., Wu, H.D., Hixson, L.J., Ahnen, D.J. and Gerner, E.W. (1997) Assessment of mutations in Ki-ras and p53 in colon cancers from azoxymethane-and dimethylhydrazine-treated rats. Mol. Carcinog., 19, 137-144.
10. Caderni, G., Filippo, D., Luceri, C., Fazi, M., Dolara, P. and Bazzicalupo, M. (1997) Apc mutations in aberrant crypt foci and colonic tumors induced by azoxymethane in rats. Proc. Am. Assoc. Cancer Res., 38, 467.
11. Takahashi, M., Fukuda, K., Sugimura, T. and Wakabayashi, K. (1998) β-Catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res., 58, 42-46.
12. Takahashi, M., Fukuda, K., Ohata, T., Sugimura, T. and Wakabayashi, K. (1997) Increased expression of inducible and endothelial constitutive nitric oxide synthases in rat colon tumors induced by azoxymethane. Cancer Res., 57, 1233-1237.
13. DuBois, R.N., Radhika, A., Reddy, B.S. and Entingh, A.J. (1996) Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology, 110, 1259-1262.
14. Shao, J., Sheng, H., Aramandla, R., Pereira, M.A., Lubet, R.A., Hawk, E., Grogan, L., Kirsch, I.R., Washington, M.K., Beauchamp, R.D. and DuBois, R.N. (1999) Coordinate regulation of cyclooxygenase-2 and TGF-β1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors. Carcinogenesis, 20, 185-191.
15. Takahashi, M., Fukutake, M., Isoi, T., Fukuda, K., Sato, H., Yazawa, K., Sugimura, T. and Wakabayashi, K. (1997) Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA). Carcinogenesis, 18, 1337-1342.
16. Takahashi, M., Minamoto, T., Sugimura, T. and Esumi, H. (1993) High frequency and low specificity of ras gene mutations in rat Zymbal's gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline. Carcinogenesis, 14, 1355-1357.
17. Stopera, S.A., Murphy, L.C. and Bird, R.P. (1992) Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer. Carcinogenesis, 13, 2081-2085.
18. Vivona, A.A., Shpitz, B., Medline, A., Bruce, W.R., Hay, K., Ward, M.A. Stern, H.S. and Gallinger, S. (1993) K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis. Carcinogenesis, 14, 1777-1781.
19. Jen, J., Powell, S.M., Papadopoulos, N., Smith, K.J., Hamilton, S.R., Vogelstein, B. and Kinzler, K.W. (1994) Molecular determinants of dysplasia in colorectal lesions. Cancer Res., 54, 5523-5526.
20. Smith, A.J., Stern, H.S., Penner, M., Hay, K., Mitri, A., Bapat, B.V. and Gallinger, S. (1994) Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res., 54, 5527-5530.
21. Otori, K., Konishi, M., Sugiyama, K., Hasebe, T., Shimoda, T., Kikuchi-Yanoshita, R., Mukai, K., Fukushima, S., Miyaki, M. and Esumi, H. (1998) Infrequent somatic mutation of the adenomatous polyposis coli gene in aberrant crypt foci of human colon tissue. Cancer, 83, 896-900.
22. Ichii, S., Takeda, S., Horii, A., Nakatsuru, S., Miyoshi, Y., Emi, M., Fujiwara, Y., Koyama, K., Furuyama, J., Utsunomiya, J. and Nakamura, Y. (1993) Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP). Oncogene, 8, 2399-2405.
23. Aberle, H., Bauer, A., Stappert, J., Kispert, A. and Kemler, R. (1997) β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J., 16, 3797-3804.
24. Chen, Z., Hagler, J., Palombella, V.J., Melandri, F., Scherer, D., Ballard, D. and Maniatis, T. (1995) Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev., 9, 1586-1597.
25. Ilyas, M., Tomlinson, I.P.M., Rowan, A., Pignatelli, M. and Bodmer, W.F. (1997) β-Catenin mutations in cell lines established from human colorectal cancers. Proc. Natl Acad. Sci. USA, 94, 10330-10334.
26. Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S. and Kikuchi, A. (1998) Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J., 17, 1371-1384.
27. Behrens, J., Jerchow, B.-A., Würtele, M., Grimm, J., Asbrand, C., Wirtz, R., Kühl, M., Wedlich, D. and Birchmeier, W. (1998) Functional interaction of an axin homolog, conductin, with β-catenin, APC and GSK-3β. Science, 280, 596-599.
28. Wink, D.A., Vodovotz, Y., Laval, J., Laval, F., Dewhirst, M.W. and Mitchell, J.B. (1998) The multifaceted roles of nitric oxide in cancer. Carcinogenesis, 19, 711-721.
29. Stamler, J.S., Simon, D.I., Osborne, J.A., Mullins, M.E., Jaraki, O., Michel, T., Singel, D.J. and Loscalzo, J. (1992) S-Nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl Acad. Sci. USA, 89, 444-448.
30. Jenkins, D.C., Charles, I.G., Baylis, S.A., Lelchuk, R., Radomski, M.W. and Moncada, S. (1994) Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br. J. Cancer, 70, 847-849.
31. Klotz, T., Bloch, W., Volberg, C., Engelmann, U. and Addicks, K. (1998) Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer, 82, 1897-1903.
32. Thomsen, L.L., Lawton, F.G., Knowles, R.G., Beesley, J.E., Riveros-Moreno, V. and Moncada, S. (1994) Nitric oxide synthase activity in human gynecological cancer. Cancer Res., 54, 1352-1354.
33. Franchi, A.M., Chaud, M., Rettori, V., Suburo, A., McCann, S.M. and Gimeno, M. (1994) Role of nitric oxide in eicosanoid synthesis and uterine motility in estrogen-treated rat uteri. Proc. Natl Acad. Sci. USA, 91, 539-543.
34. Voeller, H.J., Truica, C.I. and Gelmann, E.P. (1998) β-Catenin mutations in human prostate cancer. Cancer Res., 58, 2520-2523.
35. Palacios, J. and Gamallo, C. (1998) Mutations in the β-catenin gene (CTNNBI) in endometrioid ovarian carcinomas. Cancer Res., 58, 1344-1347.
36. Fukuchi, T., Sakamoto, M., Tsuda, H., Maruyama, K., Nozawa, S. and Hirohashi, S. (1998) β-Catenin mutation in carcinoma of the uterine endometrium. Cancer Res., 58, 3526-3528.
37. Kobayashi, K., Sagae, S., Nishioka, Y., Tokino, T. and Kudo, R. (1999) Mutations of the β-catenin gene in endometrial carcinomas. Jpn J. Cancer Res., 90, 55-59.
38. Rajnakova, A., Goh, P.M.Y., Chan, S.T.F., Ngoi, S.S., Alponat, A. and Moochhala, S. (1997) Expression of differential nitric oxide synthase isoforms in human normal gastric mucosa and gastric cancer tissue. Carcinogenesis, 18, 1841-1845.
39. Horii, A., Nakatsuru, S., Miyoshi, Y., Ichii, S., Nagase, H., Kato, Y., Yanagisawa, A. and Nakamura, Y. (1992) The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res., 52, 3231-3233.
40. Tsujii, M. and DuBois, R.N. (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83, 493-501.
41. Tsujii, M., Kawano, S., Tsujii, S., Sawaoka, H., Hori, M. and DuBois, R.N. (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93, 705-716.
42. Prescott, S.M. and White, R.L. (1996) Self-promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell, 87, 783-786.
43. Howe, L.R., Subbaramaiah, K., Chung, W.J., Dannenberg, A.J. and Brown, A.M.C. (1999) Transcriptional activation of Cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. Cancer Res., 59, 1572-1577.
44. Mei, J.M., Hord, N.G., Winterstein, D.F., Donald, S.P. and Phang, J.M. (1999) Differential expression of prostaglandin endoperoxide H synthase-2 and formation of activated β-catenin-LEF-1 transcription complex in mouse colonie epithelial cells contrasting in Apc. Carcinogenesis, 20, 737-740.
45. Salvemini, D., Misko, T.P., Masferrer, J.L., Seibert, K., Currie, M.G. and Needleman, P. (1993) Nitric oxide activates cyclooxygenase enzymes. Proc. Natl Acad. Sci. USA, 90, 7240-7244.
46. Corbett, J.A., Kwon, G., Turk, J. and McDaniel, M.L. (1993) IL-1β induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry, 32, 13767-13770.
47. Salvemini, D., Seibert, K., Masferrer, J.L., Misko, T.P., Currie, M.G. and Needleman, P. (1994) Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J. Clin. Invest., 93, 1940-1947.
48. Ristimäki, A., Honkanen, N., Jänkälä, H., Sipponen, P. and Härkönen, M. (1997) Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res., 57, 1276-1280.
49. Thomsen, L.L., Miles, D.W., Happerfield, L., Bobrow, L.G., Knowles, R.G. and Moncada, S. (1995) Nitric oxide synthase activity in human breast cancer. Br. J. Cancer, 72, 41-44.
50. Parrett, M.L., Harris, R.E., Joarder, F.S., Ross, M.S., Clausen, K.P. and Robertson F.M. (1997) Cyclooxygenase-2 gene expression in human breast cancer. Int. J. Oncol., 10, 503-507.
51. Fujimoto, H., Ando, Y., Yamashita, T., Terazaki, H., Tanaka, Y., Sasaki, J., Matsumoto, M., Suga, M. and Ando, M. (1997) Nitric oxide synthase activity in human lung cancer. Jpn J. Cancer Res., 88, 1190-1198.
52. Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T. and Takahashi, T. (1998) Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res., 58, 3761-3764.
53. Wilson, K.T., Fu, S., Ramanujam, K.S. and Meltzer, S.J. (1998) Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res., 58, 2929-2934.
54. Zimmermann, K.C., Sarbia, M., Weber, A.-A., Borchard, F., Gabbert, H.E. and Schrör, K. (1999) Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res., 59, 198-204.
55. Rosbe, K.W., Prazma, J., Petrusz, P., Mims, W., Ball, S.S. and Weissler, M.C. (1995) Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Otolaryngol. Head Neck Surg., 113, 541-549.
56. Chan, G., Boyle, J.O., Yang, E.K., Zhang, F., Sacks, P.G., Shah, J.P., Edelstein, D., Soslow, R.A., Koki, A.T., Woerner, B.M., Masferrer, J.L. and Dannenberg, A.J. (1999) Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res., 59, 991-994.